Patients have the option of treating depression with Paroxetine, a medicine that is trusted and proven to be effective, safe and causing lesser side-effects compared to other anti-depressant drugs available today. This prescription oral drug, which is otherwise known as Brisdelle, Sereupin, Seroxat, Pexeva, Paxil, and Aropax, is one of the highly- reputed class of anti-depressant medicines called SSRIs, that is, Selective serotonin reuptake inhibitors.
The four other equally famous SSRI medicines are Escitalopram (Lexapro), Zoloft (sertraline), Prozac (fluoxetine) and Celexa (citalopram). The primary intention for the development of SSRI drugs is to treat depression. Doctors, however, have found good reason to also prescribe these drugs to patients suffering from obsessive–compulsive disorder (OCD), posttraumatic stress disorder (PTSD), panic disorder, anxiety disorder, eating disorder and chronic pains.
For the past two decades the anti-depressant drug that many U.S. doctors have prescribed to their patients had just been one of the SSRI medications. SSRIs boost the performance of serotonin, also called neurotransmitter, the chemical that is used by the nerves of the brain in communicating with each other (the brain is the one responsible for the production of neurotransmitter; the brain also releases this chemical, allowing it to attach itself to the receptor of other nearby nerves). SSRI drugs also prevent this neurotransmitter from being re-absorbed into the brain, resulting to more of this chemical to stimulate the brain nerves, which would result to an improvement in the patient’s mood condition.
As an SSRI, this is also how Paroxetine works; and like other SSRI drugs, its side-effects are also almost the same. One additional function Paroxetine has, however, is treatment of vasomotor symptoms due to menopause (hot flashes and night sweats are examples of these symptoms). In fact, Paroxetine is the sole non-hormonal prescription therapy that is FDA-approved for menopausal hot flashes.
Paroxetine, which is manufactured by GlaxoSmithKline, formerly SmithKline Beecham, was approved for marketing by the US Food and Drug Administration in 1992. This drug, though, is not recommended to pregnant women or those planning to become pregnant and to individuals below 18 years old. Some of its known side effects include, mild headache, drowsiness, dizziness, mild nausea, constipation, sleeping problems or insomnia, restlessness or nervousness, mild nausea, constipation, decreased sex drive, impotence and difficulty in having an orgasm.